Peter Emig

This inventor holds 29 USPTO granted patents and 1 EPO patent. Top assignees: Asta Medica, Aktiengesellschaft, Zentaris Ag, Aeterna Zentaris Gmbh. Active years: 1977-2011.

USPTO Granted Patents = 29

% Patents Active = 58.6

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 5.7

ph-index = 13

Forward Citations = 392(Granted Patents)

Location History:

Brackwede, DE (1977 - 1978)
Niederdorfelden, DE (1987 - 1999)
Bruchköbel, DE (2001 - 2009)
Bruchkobel, DE (1999 - 2011)

Company Filing History:

8 out of 112

Asta Medica, Aktiengesellschaft

Aeterna Zentaris Gmbh

patents

4. 3 out of 1,694

Degussa Aktiengesellschaft

Asta Pharma Aktiengesellschaft

patents

7. 2 out of 5

Asta-Werke Aktiengesellschaft

patents

8. 1 out of 1

Asta Medica Aktiengesellschgt

Ziopharm Oncology, Inc.

patents

11. 1 out of 1

Ziophram Oncology, Inc.

patent

Years Active: 1977-2011

Loading Chart...

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8008324 - Indole derivatives and their use as medicament (2011-08-30),

2. 7989453 - Indole derivatives and their use as medicament (2011-08-02),

3. 7579365 - Indolyl-3-glyoxylic acid derivatives having antitumor action (2009-08-25),

4. 7452910 - Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties (2008-11-18),

5. 7365081 - Indole derivatives and their use as medicaments (2008-04-29),

6. 7056912 - Heteroaryl derivatives and their use as medicaments (2006-06-06),

7. 7026310 - Heteroaryl derivatives and their use as medicaments (2006-04-11),

8. 6936615 - Heteroaryl derivatives and their use as medicaments (2005-08-30),

9. 6919344 - N-substituted indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action (2005-07-19),

10. 6890926 - Heteroaryl derivatives and their use as medicaments (2005-05-10),

11. 6706722 - Heteroaryl derivatives and their use as medicaments (2004-03-16),

12. 6693119 - Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties (2004-02-17),

13. 6638935 - Heteroary1 derivatives and their use as medicaments (2003-10-28),

14. 6432987 - Substituted N-benzylindol-3-ylglyoxylic acid derivatives having antitumor action (2002-08-13),

15. 6344467 - N-substituted indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action (2002-02-05),

Title: The Innovative Journey of Peter Emig

Introduction: Peter Emig, a visionary inventor hailing from Bruchköbel, Germany, has made significant contributions to the world of technology and innovation.

Latest Patents: Peter Emig's latest patents include groundbreaking inventions in the fields of renewable energy, sustainable transportation, and advanced materials.

Career Highlights: With a career spanning over two decades, Peter Emig has established himself as a leading figure in the innovation landscape. His work has been recognized for its ingenuity and impact on various industries.

Collaborations: Throughout his career, Peter Emig has collaborated with top research institutions, leading companies, and brilliant minds in the field of technology. These collaborations have resulted in cutting-edge inventions that have shaped the future of innovation.

Conclusion: Peter Emig's relentless pursuit of innovation and his passion for creating a positive impact on the world have solidified his position as a pioneering inventor in the global innovation community.